Span-America Medical Systems (Span-America Medical Systems) EBIT : $6.87 Mil (TTM As of Mar. 2017)

View and export this data going back to 1983. Start your Free Trial

What is Span-America Medical Systems EBIT?

Span-America Medical Systems's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2017 was $2.14 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2017 was $6.87 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Span-America Medical Systems's annualized ROC % for the quarter that ended in Mar. 2017 was 19.85%. Span-America Medical Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2017 was 56.75%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Span-America Medical Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2017 was 8.28%.

Span-America Medical Systems EBIT Historical Data

The historical data trend for Span-America Medical Systems's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Span-America Medical Systems EBIT Chart

Span-America Medical Systems Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

EBIT

Get a 7-Day Free Trial

7.49

7.30

3.64

5.67

6.08

Span-America Medical Systems Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
EBIT	Get a 7-Day Free Trial															1.11	1.42	1.88	1.43	2.14

Competitive Comparison of Span-America Medical Systems's EBIT

For the Medical Devices subindustry, Span-America Medical Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Span-America Medical Systems's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Span-America Medical Systems's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Span-America Medical Systems's EV-to-EBIT falls into.

Span-America Medical Systems EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.87 Mil.

Span-America Medical Systems (NAS:SPAN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Span-America Medical Systems's annualized ROC % for the quarter that ended in Mar. 2017 is calculated as:

	ROC % (Q: Mar. 2017 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2016 )	+	Invested Capital (Q: Mar. 2017 ))	/ count )
=	5.612 * ( 1 - 19.95% )	/	( (23.568	+	21.692)	/ 2 )
=	4.492406	/	22.63
=	19.85 %

where

	Invested Capital		(Q: Dec. 2016 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	33.159	-	5.323	-	( 4.268	-	max(0, 5.323	-	20.174	+	4.268	))
=	23.568

	Invested Capital		(Q: Mar. 2017 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	33.9	-	4.934	-	( 7.274	-	max(0, 4.934	-	23.561	+	7.274	))
=	21.692

Note: The Operating Income data used here is four times the quarterly (Mar. 2017) data.

2. Joel Greenblatt's definition of Return on Capital:

Span-America Medical Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2017 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2017 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2016		Q: Mar. 2017
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	8.56	/	( ( (4.17 + max(10.583, 0))	+	(4.059 + max(11.353, 0)) )	/	2 )
=	8.56	/	( ( 14.753	+	15.412 )	/	2 )
=	8.56	/	15.0825
=	56.75 %

where Working Capital is:

	Working Capital		(Q: Dec. 2016 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(7.299	+	7.172	+	1.435)	-	(5.323	+	0	+	0)
=	10.583

	Working Capital		(Q: Mar. 2017 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(7.434	+	7.371	+	1.482)	-	(4.934	+	0	+	0)
=	11.353

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2017) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Span-America Medical Systems's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2017 )
	=	6.868	/	82.910
	=	8.28 %

Span-America Medical Systems EBIT Related Terms

Thank you for viewing the detailed overview of Span-America Medical Systems's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Span-America Medical Systems (Span-America Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Span-America Medical Systems Inc (NAS:SPAN) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.spanamerica.com

Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.

Executives

Terry Allison Rappuhn	director	P O BOX 58062, NASHVILLE TN 37205
Thomas Joseph Sullivan	director	64 PETTIT PL PRINCETON NJ 08540
Robert B Johnston	director

Span-America Medical Systems (Span-America Medical Systems) Headlines

From GuruFocus

Span-America (SPAN) – 2010 Review + Future Outlook

By asues asues • 01-21-2011

Span-America Medical Systems: 92nd Consecutive Dividend and Debt Free

By Mark Lin Mark Lin • 12-04-2012

SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 02-16-2010

SpanAmerica Medical Systems Inc. Reports Operating Results (10-Q)

By gurufocus • 02-11-2009